Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1390777 NEW YORK, NY
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$4,928,850
+$1,438,507 QoQ
Shares Held
274,435
+9.3% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 207 holders
Holding Since
Mar 2022
15 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. AMLX ranks #23 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,322,319 $238,741,833
2 VTRS
Viatris Inc
 14,288,053 $226,894,274
3 UTHR
UNITED THERAPEUTICS Corp
 294,413 $159,521,790
4 NBIX
Neurocrine Biosciences Inc
 699,125 $117,830,519
5 ELAN
Elanco Animal Health Inc
 3,411,532 $83,957,795
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,899,912 $64,369,013
7 ALKS
Alkermes plc.
 1,097,282 $57,497,573
8 LNTH
Lantheus Holdings, Inc.
 441,831 $49,016,724

All Filings in AMLX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,928,850 274,435
2026-03-31 $3,490,343 251,104
2025-12-31 $2,625,551 217,347
2025-09-30 $2,486,370 182,956
2025-06-30 $966,864 150,837
2024-09-30 $76,719 23,679
2024-03-31 $562,400 198,029
2023-12-31 $2,811,518 191,000
2023-09-30 $2,995,423 163,595
2023-06-30 $3,534,912 163,881
2023-03-31 $6,004,605 204,656
2022-12-31 $7,764,633 210,139
2022-09-30 $3,291,972 116,944
2022-06-30 $558,944 29,021
2022-03-31 $339,894 26,451